20 articles
A Phase 2 trial explores whether oral curcumin can enhance Avastin/FOLFIRI chemotherapy outcomes in patients with unresectable colorectal metastases.
Novel KH-1 supplement containing spermidine and probiotics tested for autophagy stimulation and glucose control in 42 prediabetic participants.
A Phase 2 pilot trial investigates whether the natural senolytic compound fisetin can reduce dysfunction and complications in COVID-19 patients.
Small pilot study tests whether resistant starch from potatoes can safely modify gut bacteria in cancer patients receiving dual checkpoint inhibitors.
Italian researchers test plant-based compounds for brain health and quality of life in aging adults with promising early results.
A Phase 1/2 trial tests whether combining durvalumab, tremelimumab, and FOLFOX chemotherapy can safely boost immune response in mCRC.
Clinical trial tests whether senolytic compounds can reduce cellular aging burden and improve bone health markers in older adults.
A completed French trial explores how gut and airway microbiota, blood, and sputum biomarkers relate to immunotherapy outcomes in metastatic NSCLC.
Clinical trial tests whether dasatinib plus quercetin can reduce liver scarring in fatty liver disease patients.
A completed phase I trial tests regorafenib plus dual checkpoint inhibitors in 39 patients with hard-to-treat metastatic colorectal cancer.
New study shows how analyzing fluid from lungs can detect cancer mutations and guide personalized treatment decisions.
246-person study tested whether inulin fiber from Jerusalem artichokes could help prediabetic patients return to normal blood sugar levels.
Small trial tests novel three-drug approach combining immune checkpoint inhibitor, vaccine, and inflammation blocker for metastatic cancers.
Study tests whether omega-3 rich flax oil enhances resistance training benefits for muscle mass and inflammation in older adults.
12-week trial tested omega-3 rich camelina oil snacks in 91 healthy adults over 65 for anti-inflammatory effects.
Small trial explores how popular greens supplement affects microbiome and blood nutrient markers in healthy adults over 7 weeks.
Chinese researchers tested nucleotide supplements against aging markers in 122 participants over 4 months with promising early results.
Cornell study tests whether N-acetylcysteine can restore protective antioxidants in Parkinson's patients' brains using advanced brain imaging.
24-week trial tested fucoxanthin-rich microalgae supplement on memory, attention, and executive function in 66 healthy seniors.
A completed trial tests whether phenolic-rich olive oil plus FOS and inulin can reverse sarcopenia and cut cardiovascular risk in 60–80-year-olds.
